Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renato Bertini Malgarini

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|May 26, 2004
Etanercept and methotrexate in rheumatoid arthritisRenato Bertini Malgarini, Giuseppe Pimpinella
The New England Journal of Medicine|April 8, 2011
Preexposure chemoprophylaxis for HIV preventionGiuseppe Pimpinella, Renato Bertini Malgarini
The New England Journal of Medicine|February 29, 2008
Effects of growth hormone-releasing factor in HIV-infected patientsRenato Bertini Malgarini, Giuseppe Pimpinella
JAMA|August 26, 2010
High-dose oral vitamin D supplementation and risk of falls in older womenRenato Bertini Malgarini, Giuseppe Pimpinella
Lancet (London, England)|July 12, 2011
Phentermine plus topiramate in the treatment of obesityRenato Bertini Malgarini, Giuseppe Pimpinella
The New England Journal of Medicine|January 27, 2012
Briakinumab versus methotrexate for psoriasisRenato Bertini Malgarini, Giuseppe Pimpinella
The New England Journal of Medicine|May 1, 2009
Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis CRenato Bertini Malgarini, Giuseppe Pimpinella
Lancet (London, England)|November 30, 2004
Statins for patients with type 2 diabetesGiuseppe Pimpinella, Renato Bertini Malgarini, Nello Martini
Expert Opinion on Biological Therapy|June 29, 2013
Biosimilars: the paradox of sharing the same pharmacological action without full chemical identityLuca Pani, Simona Montilla, Giuseppe Pimpinella, et al.
Drug Safety|September 16, 2015
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A National Analysis of Data from 10-Year Post-marketing SurveillanceFrancesca Renda, Giovanni Landoni, Renato Bertini Malgarini, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|May 26, 2004
Etanercept and methotrexate in rheumatoid arthritisRenato Bertini Malgarini, Giuseppe Pimpinella
The New England Journal of Medicine|April 8, 2011
Preexposure chemoprophylaxis for HIV preventionGiuseppe Pimpinella, Renato Bertini Malgarini
The New England Journal of Medicine|February 29, 2008
Effects of growth hormone-releasing factor in HIV-infected patientsRenato Bertini Malgarini, Giuseppe Pimpinella
JAMA|August 26, 2010
High-dose oral vitamin D supplementation and risk of falls in older womenRenato Bertini Malgarini, Giuseppe Pimpinella
Lancet (London, England)|July 12, 2011
Phentermine plus topiramate in the treatment of obesityRenato Bertini Malgarini, Giuseppe Pimpinella
The New England Journal of Medicine|January 27, 2012
Briakinumab versus methotrexate for psoriasisRenato Bertini Malgarini, Giuseppe Pimpinella
The New England Journal of Medicine|May 1, 2009
Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis CRenato Bertini Malgarini, Giuseppe Pimpinella
Lancet (London, England)|November 30, 2004
Statins for patients with type 2 diabetesGiuseppe Pimpinella, Renato Bertini Malgarini, Nello Martini
Expert Opinion on Biological Therapy|June 29, 2013
Biosimilars: the paradox of sharing the same pharmacological action without full chemical identityLuca Pani, Simona Montilla, Giuseppe Pimpinella, et al.
Drug Safety|September 16, 2015
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A National Analysis of Data from 10-Year Post-marketing SurveillanceFrancesca Renda, Giovanni Landoni, Renato Bertini Malgarini, et al.
Pageof 1